Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-27 Sale | 2023-11-29 09:14 am | CARDINAL HEALTH INC | CAH | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | 36,642 | $106.31 | $3,895,411 | 35,202 (Direct) | View |
| 2023-08-28 Sale | 2023-08-29 4:21 pm | CARDINAL HEALTH INC | CAH | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | 6,712 | $89.81 | $602,805 | 44,202 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-01 Tax Withholding | 2023-12-05 4:42 pm | N/A N/A | CARDINAL HEALTH INC | CAH | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | 638 | $107.08 | 34,564 (Direct) | View |
| 2023-11-27 Exercise | 2023-11-29 09:14 am | N/A N/A | CARDINAL HEALTH INC | CAH | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | 15,373 | $66.43 | 35,202 (Direct) | View |
| 2023-11-27 Exercise | 2023-11-29 09:14 am | N/A 2025-08-15 | CARDINAL HEALTH INC | CAH | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | 27,642 | $0 | 35,202 (Direct) | View |
| 2023-11-27 Exercise | 2023-11-29 09:14 am | N/A N/A | CARDINAL HEALTH INC | CAH | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | 6,279 | $83.19 | 35,202 (Direct) | View |
| 2023-11-27 Exercise | 2023-11-29 09:14 am | N/A N/A | CARDINAL HEALTH INC | CAH | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | 5,990 | $84.27 | 35,202 (Direct) | View |
| 2023-08-28 Exercise | 2023-08-29 4:21 pm | N/A N/A | CARDINAL HEALTH INC | CAH | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | 6,712 | $71.43 | 44,202 (Direct) | View |
| 2023-08-28 Exercise | 2023-08-29 4:21 pm | N/A 2024-08-15 | CARDINAL HEALTH INC | CAH | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | 6,712 | $0 | 44,202 (Direct) | View |
| 2023-08-16 Option Award | 2023-08-17 7:51 pm | N/A N/A | CARDINAL HEALTH INC | CAH | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | 15,487 | $0 | 44,202 (Direct) | View |
| 2023-08-15 Tax Withholding | 2023-08-17 7:51 pm | N/A N/A | CARDINAL HEALTH INC | CAH | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | 10,966 | $92.99 | 44,202 (Direct) | View |
| 2023-08-07 Option Award | 2023-08-08 7:42 pm | N/A N/A | CARDINAL HEALTH INC | CAH | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | 12,760 | $0 | 39,681 (Direct) | View |
| 2022-12-01 Tax Withholding | 2022-12-05 4:29 pm | N/A N/A | CARDINAL HEALTH INC | CAH | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | 380 | $80.17 | 26,921 (Direct) | View |
Ownership | 2022-09-29 08:31 am | N/A N/A | CARDINAL HEALTH INC | CAH | WEITZMAN DEBORAH CEO, Pharmaceutical Segment | 0 | $0 | 61,655 (Direct) | View |